Nialamide

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Image:Nialamide.svg
Nialamide
Systematic (IUPAC) name
N-benzyl-3-(N'-pyridin-4-ylcarbonylhydrazino) -propanamide
Identifiers
CAS number 51-12-7
ATC code N06AF02
PubChem 4472
Chemical data
Formula C16H18N4O2 
Mol. mass 298.34 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion Renal[1]
Therapeutic considerations
Pregnancy cat.

?

Legal status

Prescription only

Routes Oral, intramuscular,[1] intravenous[2]

Nialamide was one of the first MAOI (monoamine oxidase inhibitor) antidepressants. It is chemically related to iproniazide, another MAOI derived from isonicotinic acid.

Uses

Approved

Nialamide is effective for depression characterized by anergic symptoms,[3] endogenous depression,[4] and reactive depression.[5]

Unapproved/Off-Label/Investigational

Nialamide is sometimes used in the treatment of trigeminal neuralgia. It has also been studied for alcoholism,[6] dermatomally distributed vitiligo,[7] irregular menstrual cycle,[8], angina,[9] cerebrovascular disorders,[10] and the prevention of streptomycin-induced deafness.[11]

Side effects

Side effects of nialamide include insomnia, vertigo, hyperhidrosis, weight gain, vomiting, tachycardia, constipation, dry mouth, upset stomach, orthostatic hypotension and decreased systolic pressure.

Tradenames

Nialamide is sold under Psicodisten®, Niaquitil®, Nialamid®, Niamidal®, Niamide®, Novazid®, Nuredal®, Niamid® (Italy, Belgium, Netherlands, England, United States),[1] Niazin®, Nyazin®, Surgex® (Italy),[1] Mygal®, Delmoneurina®, Isalizina® (Italy),[1] Espril® (Italy),[1] and Nyezin®.[1]

References and End Notes

  1. ^  Benady DR, Clein LJ, Pare CM (1965). "Intramuscular nialamide in intractable depression". Diseases of the Nervous System 26 (12): 792-4. [No abstract] PMID 5321917 List of Print Collections
  2. ^  Oules J, Cabazon (1964). "[TREATMENT OF DEPRESSIVE STATES WITH INTRAVENOUS NIAMIDE.]". Toulouse Medical 65 (1): 1298-302. PMID 14272189. [Article in French] New York Academy of Medicine Library holding
  3. ^  Vaisberg M, McGahee CL, Radinger N, Saunders JC (1959). "Nialamide for the treatment of anergy and depression". Diseases of the Nervous System 20 (Supplemental): 22-5. PMID 13840714. List of Library Holdings
  4. ^  Van Reeth PC, Bloch C (1960). "[Treatment of endogenous depressions by a new inhibitor of monoamine oxidase: nialamide.]". Acta Neurologica Belgica 60 (1): 320-7. [Article in French] PMID 13841128 Harvard University Library Holding
  5. ^  Cormary M (1966). "[Use of parenteral nialamide in the treatment of reactive or neurotic depressive states]". Lyon Medical 215 (15): 1051-62. [Article in French] PMID 5930244 List of Library Holdings
  6. ^  Bobrov AE, Shurygin AN, Krasil'nikov SB (1991). "[Effectiveness of combined use of monoamine oxidase inhibitors and psychotherapy in the treatment of chronic alcoholism]". Zhurnal Nevropatologii i Psikhiatrii Imeni SS Korsakova. 91 (2): 79-83. [Article in Russian] PMID 1647635 List of Library Holdings
  7. ^  Koga M (1977). "Vitiligo: a new classification and therapy". British Journal of Dermatology 97 (3): 255-61. PMID 921895. List of Library Holdings
  8. ^  Gautray JP, Jolivet A (1976). "[Neuroendocrine investigation and therapy of the menstrual cycle disorders (author's transl)(proceedings)]". Annales d'Endocrinologie 37 (4): 293-4. PMID 1022189. List of Library Holdings
  9. ^  Barats SS, Oranskii IE, Kartashova DI, Gorovater EN (1976). "[Comparative clinico-physiological study of the effect of several MAO inhibitors in stenocardia]". Kardiologiia 16 (3): 138-40. [Article in Russian] No absract. PMID 1021625 List of Library Holdings
  10. ^  Mirzoian RS (1975). "[Prevention of cerebrovascular disorders with adrenergic substances]". Biulleten' Eksperimental'noi Biologii i Meditsiny 80 (11): 50-3. [Article in Russian] PMID 1218262 List of Library Holdings
  11. ^  Semczuk B, Klonowski S, Golabek W (1974). "The protective effect of niamid on hearing in patients treated with large doses of streptomycin". Annales Universitatis Mariae Curie-Sklodowska Sectio D: Medicina 29 (1): 193-7. No abstract. PMID 4467804 List of Library Holdings


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
In other languages